CalciMedica
Stephen Bardin is an accomplished financial executive with extensive experience in various leadership roles. Currently serving as Chief Financial Officer at CalciMedica, Stephen has also worked as an Independent Consultant. As an Advisor and former Chief Financial Officer at atai Life Sciences, Stephen provided strategic financial guidance. At BridgeBio, responsibilities included Senior Vice President of Finance and Operations, Vice President of Finance and Operations, and Senior Director of Finance and Operations. Stephen's earlier career featured positions such as Director and Associate Director of Corporate Development at Myovant Sciences, showcasing a strong background in corporate development and financial operations.
This person is not in any teams
CalciMedica
CalciMedica is a privately held, clinical-stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases.